The Management of Recurrent Ovarian Cancer
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 34, S1-S15
- https://doi.org/10.1053/j.seminoncol.2007.03.012
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Origins and molecular pathology of ovarian cancerLaboratory Investigation, 2005
- Early events in ovarian oncogenesisReproductive Biology and Endocrinology, 2003
- A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian CancerJNCI Journal of the National Cancer Institute, 2003
- Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003
- Ovulation and risk of epithelial ovarian cancerInternational Journal of Cancer, 2003
- Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control StudyAmerican Journal of Epidemiology, 2002
- Family history of ovarian cancerCurrent Obstetrics & Gynaecology, 2002
- Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian CancerJAMA, 2000
- Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad LigamentInternational Journal of Gynecological Pathology, 1999
- Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.Journal of Clinical Oncology, 1998